Clinical Trials

Zura Bio to Participate in Upcoming Investor Conferences

by
Zura Bio management team preparing for investor meetings at biotech conferences in Miami, representing clinical-stage immunology advancements.

Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotech firm advancing innovative therapies for autoimmune and inflammatory diseases, has announced that its management team will engage with investors at two major conferences in Miami next week. The schedule includes a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026, followed by one-on-one meetings … Read more

Iksuda Therapeutics Showcases Encouraging Phase 1 Results for IKS014 in HER2+ Oesophageal Cancer

by
Conceptual illustration of antibody-drug conjugate targeting HER2-positive cancer cells in the esophagus

“Iksuda Therapeutics is set to highlight preliminary data from its Phase 1 trial of IKS014, a HER2-targeted antibody-drug conjugate, at the ASCO Gastrointestinal Cancers Symposium. The analysis reveals an 80% clinical benefit rate in pretreated patients with advanced HER2+ oesophageal cancer, underscoring potential advancements in treating this challenging malignancy.” Study Overview Iksuda Therapeutics, a UK-based … Read more